These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10571160)

  • 1. New pyrrole derivatives as antimycobacterial agents analogs of BM212.
    Biava M; Fioravanti R; Porretta GC; Deidda D; Maullu C; Pompei R
    Bioorg Med Chem Lett; 1999 Oct; 9(20):2983-8. PubMed ID: 10571160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimycobacterial compounds. New pyrrole derivatives of BM212.
    Biava M; Porretta GC; Deidda D; Pompei R; Tafi A; Manetti F
    Bioorg Med Chem; 2004 Mar; 12(6):1453-8. PubMed ID: 15018918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of the thiomorpholine introduction in new pyrrole derivatives as antimycobacterial agents analogues of BM 212.
    Biava M; Cesare Porretta G; Deidda D; Pompei R; Tafi A; Manetti F
    Bioorg Med Chem; 2003 Feb; 11(4):515-20. PubMed ID: 12538016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimycobacterial compounds. Optimization of the BM 212 structure, the lead compound for a new pyrrole derivative class.
    Biava M; Porretta GC; Poce G; Deidda D; Pompei R; Tafi A; Manetti F
    Bioorg Med Chem; 2005 Feb; 13(4):1221-30. PubMed ID: 15670931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New derivatives of BM212: A class of antimycobacterial compounds based on the pyrrole ring as a scaffold.
    Biava M; Porretta GC; Manetti F
    Mini Rev Med Chem; 2007 Jan; 7(1):65-78. PubMed ID: 17266639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of new leads against Mycobacterium tuberculosis using scaffold hopping and shape based similarity.
    Wavhale RD; Martis EAF; Ambre PK; Wan B; Franzblau SG; Iyer KR; Raikuvar K; Macegoniuk K; Berlicki Ł; Nandan SR; Coutinho EC
    Bioorg Med Chem; 2017 Sep; 25(17):4835-4844. PubMed ID: 28778369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings.
    Biava M; Porretta GC; Poce G; De Logu A; Saddi M; Meleddu R; Manetti F; De Rossi E; Botta M
    J Med Chem; 2008 Jun; 51(12):3644-8. PubMed ID: 18494459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BM 212 and its derivatives as a new class of antimycobacterial active agents.
    Biava M
    Curr Med Chem; 2002 Nov; 9(21):1859-69. PubMed ID: 12369872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimycobacterial agents. Novel diarylpyrrole derivatives of BM212 endowed with high activity toward Mycobacterium tuberculosis and low cytotoxicity.
    Biava M; Porretta GC; Poce G; Supino S; Deidda D; Pompei R; Molicotti P; Manetti F; Botta M
    J Med Chem; 2006 Aug; 49(16):4946-52. PubMed ID: 16884306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212.
    La Rosa V; Poce G; Canseco JO; Buroni S; Pasca MR; Biava M; Raju RM; Porretta GC; Alfonso S; Battilocchio C; Javid B; Sorrentino F; Ioerger TR; Sacchettini JC; Manetti F; Botta M; De Logu A; Rubin EJ; De Rossi E
    Antimicrob Agents Chemother; 2012 Jan; 56(1):324-31. PubMed ID: 22024828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal activities of the pyrrole derivative BM212 against multidrug-resistant and intramacrophagic Mycobacterium tuberculosis strains.
    Deidda D; Lampis G; Fioravanti R; Biava M; Porretta GC; Zanetti S; Pompei R
    Antimicrob Agents Chemother; 1998 Nov; 42(11):3035-7. PubMed ID: 9797251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Synthesis of 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and N-Adamantan-2-yl-N'-((E)-3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine (SQ109) Pyrrole Hybrid Derivatives: Discovery of Potent Antitubercular Agents Effective against Multidrug-Resistant Mycobacteria.
    Bhakta S; Scalacci N; Maitra A; Brown AK; Dasugari S; Evangelopoulos D; McHugh TD; Mortazavi PN; Twist A; Petricci E; Manetti F; Castagnolo D
    J Med Chem; 2016 Mar; 59(6):2780-93. PubMed ID: 26907951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tapping into the antitubercular potential of 2,5-dimethylpyrroles: A structure-activity relationship interrogation.
    Semenya D; Touitou M; Masci D; Ribeiro CM; Pavan FR; Dos Santos Fernandes GF; Gianibbi B; Manetti F; Castagnolo D
    Eur J Med Chem; 2022 Jul; 237():114404. PubMed ID: 35486992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel carbazole tethered pyrrole derivatives as potent inhibitors of Mycobacterium tuberculosis.
    Surineni G; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2015 Feb; 25(3):485-91. PubMed ID: 25559743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation.
    Biava M; Porretta GC; Poce G; De Logu A; Meleddu R; De Rossi E; Manetti F; Botta M
    Eur J Med Chem; 2009 Nov; 44(11):4734-8. PubMed ID: 19595488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimycobacterial pyrroles: synthesis, anti-Mycobacterium tuberculosis activity and QSAR studies.
    Ragno R; Marshall GR; Di Santo R; Costi R; Massa S; Rompei R; Artico M
    Bioorg Med Chem; 2000 Jun; 8(6):1423-32. PubMed ID: 10896119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrrolnitrin and related pyrroles endowed with antibacterial activities against Mycobacterium tuberculosis.
    Di Santo R; Costi R; Artico M; Massa S; Lampis G; Deidda D; Pompei R
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2931-6. PubMed ID: 9873650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of novel pyrrole derivatives as potential ClpP1P2 inhibitor against Mycobacterium tuberculosis.
    Liu P; Yang Y; Ju Y; Tang Y; Sang Z; Chen L; Yang T; An Q; Zhang T; Luo Y
    Bioorg Chem; 2018 Oct; 80():422-432. PubMed ID: 30005200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antimycobacterial activity of a new quinolone, NM394].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Aug; 68(8):517-20. PubMed ID: 8397311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.